Skip to content

CLLS

Cellectis SA

NASDAQ · Healthcare · Biotechnology · FR

$1.53
+4.79%
Ask drillr
Institutional positioning

13F filings over the trailing two quarters

New 8Increased 5Reduced 23Sold out 8
FilerActionSharesFiled
B Group, Inc.Unchanged3,281,501Aug 14, 2026
B GROUP, INC.Unchanged3,281,501May 15, 2026
UBS ASSET MANAGEMENT AMERICAS INCUnchanged3,178,620May 13, 2026
LONG FOCUS CAPITAL MANAGEMENT, LLCReduced2,744,098May 15, 2026
Long Focus Capital Management, LLCReduced2,741,853Aug 14, 2026
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCReduced2,644,881Aug 13, 2026
BLACKROCK, INC.Reduced341,523May 13, 2026
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.Unchanged226,875Aug 14, 2026
MACQUARIE MANAGEMENT HOLDINGS, INC.Unchanged226,875May 15, 2026
BlackRock, Inc.Reduced225,444Aug 7, 2026
MORGAN STANLEYReduced86,776May 15, 2026
MORGAN STANLEYReduced85,455Aug 13, 2026
LPL Financial LLCIncreased84,415Aug 7, 2026
LPL FINANCIAL LLCReduced84,345May 6, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPIncreased65,942May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings